Is dopamine administration possibly a risk factor for delirium?

Area of Science:

• Critical Care Medicine
• Neuroscience
• Pharmacology

Background:

• Delirium is a common and serious complication in hospitalized patients.
• Dopamine, a vasoactive agent, is frequently used in critical care settings.
• The potential link between dopamine administration and delirium has not been fully elucidated.

Purpose of the Study:

• To investigate the association between intravenous dopamine administration and the subsequent need for haloperidol, an indicator of delirium.
• To determine if dopamine is a risk factor for delirium in hospitalized patients.

Main Methods:

• Retrospective analysis of 21,844 inpatient admissions at a university hospital.
• Multivariate logistic regression was employed to assess the predictive value of dopamine for haloperidol requirement.
• Analysis included adjustments for illness severity indicators like ICU admission and diagnostic related group weight.

Main Results:

• Dopamine administration was associated with a nearly threefold increase in the odds of requiring haloperidol (Odds Ratio = 2.89, p < .0001).
• This association remained significant even after controlling for illness severity.
• The increased risk was observed across various age groups (after age 20) and within the intensive care unit population.

Conclusions:

• A potent association exists between dopamine administration and the need for haloperidol, suggesting dopamine may be a risk factor for delirium.
• Limitations include the retrospective design and the use of haloperidol as a proxy for delirium.
• Prospective studies are recommended to confirm causality and explore prophylactic strategies for delirium in patients receiving dopamine.